XML 34 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Going Concern (Details Narrative) (USD $)
 3 Months Ended 113 Months Ended
Dec. 31, 2014
Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.   $ 41,645,688us-gaap_OtherNoncashIncome
Net Losses   19,377,575us-gaap_OtherComprehensiveIncomeOtherNetOfTax
Equity in Net Losses of Entest Biomedical, Inc.   663,649us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
Net borrowings 217,321us-gaap_ProceedsFromLoans  
Common stock issued for cash, Shares 666,668BMSN_StockIssuedDuringPeriodSharesIssuedForCash2  
Common stock issued for cash, Amount $ 50,000BMSN_StockIssuedDuringPeriodValueIssuedForCash2